Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIL0A.L Regulatory News (IL0A)

  • There is currently no data for IL0A

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale Agreed for Non-Core UK Assets

27 Oct 2016 07:00

RNS Number : 5690N
Permanent TSB Group Holdings PLC
27 October 2016
 

This announcement contains Inside Information as defined under Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse.

 

Statement by Permanent TSB Group Holdings plc

Permanent TSB plc (trading as Permanent TSB) is the wholly owned retail banking subsidiary of Permanent TSB Group Holdings plc.

 

Headline: Permanent TSB agrees sale of GBP£2.29 billion of non-core loans held by Lansdowne 199 Ltd in the United Kingdom.

 

Thursday 27th October 2016. Permanent TSB has agreed the sale of GBP£2.29 billion of loans held by its UK subsidiary, Lansdowne 199 Ltd (L199). The loan assets comprise the total balance of the residual book of the Group's former UK subsidiary, Capital Home Loans Limited (CHL). The residual book was transferred to L199 in July 2015 following the sale of circa 50% of the CHL loan portfolio and the associated legal entity, CHL, to an affiliate of Cerberus Capital Management, L.P. This transaction, once completed, means that the Group will have successfully de-leveraged 100% of the CHL loan portfolio, as required under the Group's Restructuring Plan. 

 

The acquirer of the loans is an affiliate of Cerberus Capital Management, L.P. The Group was advised by Morgan Stanley & Co International plc. The gross proceeds for the sale of GBP£2.29 billion of loan assets (RWAs of GBP£855 million) is circa GBP£1.95 billion. Consideration is in the form of a cash settlement and sales proceeds will be used to reduce the Group's borrowings.

 

At 31 December 2015, losses attributable to the assets to be disposed were circa GBP£8.9 million (circa €12.3 million)[1]. On completion, the transaction is estimated to have a net adverse impact on the capital of the Group of circa GBP£300 million (circa €333 million at current exchange rates), which takes into account all estimated fees and costs with the completion of the transaction. The sale is expected to close before the 31 December 2016.

 

Speaking today, Jeremy Masding, Group Chief Executive, said that the sale of these assets was a significant event for the Group; "This transaction is a milestone event for the Group. Its completion in the coming weeks will conclude the very ambitious deleveraging programme of some €8.4 billion which was set out for the Group under the Restructuring Plan agreed with the European authorities.

 

Perhaps most importantly, it will complete our pivot to the Irish retail and SME marketplace and allow us to focus exclusively on growing our commercial position in key segments of the market here. That is now our overriding priority, as Ireland's only pure domestic retail and SME bank."

 

 

Contacts

Investors and Analysts

Rajesh ManirajanHead of Investor Relationsrajesh.manirajan@permanenttsb.ie+353 1 669 5622

 

Media

Ray GordonGordon MRMptsb@gordonmrm.ie+353 87 241 7373

 

 


[1] The income statement impacts for L199 are based on the 2015 average rate of GBP£0.725/€. Note this takes account of the period from L199 establishment in July 2015 to December 2015.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISMFBBTMBATTPF
Date   Source Headline
26th Nov 20203:30 pmRNSDirector Declaration
25th Nov 20202:22 pmRNSStabilisation Notice
18th Nov 20209:10 amRNSStabilisation Notice
3rd Nov 20207:00 amRNSTrading Statement
27th Oct 20207:00 amRNSSale of Buy To Let Loan Portfolio
12th Oct 20202:00 pmRNSDirector Declaration
29th Sep 20204:30 pmRNSAppointment of Senior Independent Director
25th Sep 202010:00 amRNSAppointment of Interim CFO
12th Aug 20204:00 pmRNSDirector/PDMR Shareholding
5th Aug 20203:00 pmRNSDirectorate Change
5th Aug 20203:00 pmRNSResult of AGM
4th Aug 20207:00 amRNSCommentary on Half-Year Report
4th Aug 20207:00 amRNSHalf-year Report
6th Jul 202012:00 pmRNSNotice of AGM
6th Jul 202012:00 pmRNSEuronext Listing Rules 6.1.82(1) & (2) Disclosure
22nd Jun 202010:00 amRNSAppointment of Chief Executive Officer
14th May 20207:00 amRNSTrading Statement
20th Mar 202012:00 pmRNSConvening of Annual General Meeting Deferred
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
26th Feb 20207:00 amRNSCommentary on Annual Financial Report
26th Feb 20207:00 amRNSAnnual Financial Report
24th Feb 20204:41 pmRNSSecond Price Monitoring Extn
24th Feb 20204:37 pmRNSPrice Monitoring Extension
28th Jan 20204:00 pmRNSDirectorate Change
6th Nov 20197:00 amRNSTrading Statement
29th Oct 20194:00 pmRNSDirector Declaration
29th Oct 20193:00 pmRNSDirectorate Change
24th Oct 20192:00 pmRNSChief Executive To Step Down During 2020
2nd Oct 201910:00 amRNSDirector Declaration
26th Sep 201912:27 pmRNSStabilisation Notice
24th Sep 20193:30 pmRNSDirectorate Changes
19th Sep 20195:00 pmRNSDirector Declaration
19th Sep 201911:17 amRNSStabilisation Notice
12th Sep 20192:00 pmRNSSale of Non-Performing Loan Portfolio
3rd Sep 201911:00 amRNSDirector/PDMR Shareholding
3rd Sep 201911:00 amRNSDirector/PDMR Shareholding
6th Aug 20194:00 pmRNSDirector/PDMR Shareholding
29th Jul 201910:00 amRNSDirector/PDMR Shareholding
29th Jul 201910:00 amRNSDirector/PDMR Shareholding
26th Jul 20195:00 pmRNSHalf-year Report
25th Jul 20197:00 amRNSHalf-year Report
25th Jul 20197:00 amRNS2019 Half Year Report Commentary
30th May 20192:00 pmRNSConclusion of Tracker Enforcement Investigation
14th May 20194:30 pmRNSResult of AGM
9th May 20197:00 amRNSTrading Update
29th Mar 20193:30 pmRNSNotice of AGM
27th Feb 20197:00 amRNSAnnual Financial Report
27th Feb 20197:00 amRNS2018 Full Year Report Commentary
29th Nov 20184:00 pmRNSSecuritisation of a Non-Performing Loan Portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.